🔗 Share this article

Treasury head Rachel Reeves has stated she is preparing "focused action to tackle household expense pressures" in the forthcoming Budget.

During an interview with media outlets, she stated that curbing price rises is a shared responsibility of both the administration and the central bank.

The United Kingdom's price growth is expected to be the most elevated among the G7 advanced economies this year and the following year.

Potential Energy Bill Measures

Reports indicate the administration could take action to reduce utility costs, such as by cutting the current 5% level of value-added tax charged on energy supplies.

Another option is to reduce some of the policy costs presently included in bills.

Fiscal Constraints and Expert Expectations

The government will receive the latest report from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much space there is for these actions.

The consensus from most analysts is that the Chancellor will have to announce tax rises or budget cuts in order to fulfill her voluntary fiscal targets.

Earlier on the same day, calculations showed there was a £22 billion shortfall for the chancellor to address, which is at the more modest range of expectations.

"There's a collective job between the Bank of England and the government to continue tackling some of the sources of price increases," Reeves told the BBC in Washington, at the conferences of the International Monetary Fund and World Bank.

Tax Commitments and International Concerns

While a great deal of the attention has been on expected tax rises, the chancellor said the latest data from the fiscal watchdog had not altered her commitment to campaign commitments not to raise tax levels on earnings tax, sales tax or National Insurance.

She attributed an "unpredictable world" with increasing international and trade tensions for the Budget tax moves, probably to be focused on those "most able to pay."

Global Economic Tensions

Commenting on worries about the United Kingdom's economic relations with China she said: "Our security interests always come first."

Last week's declaration by Chinese authorities to tighten export controls on critical minerals and other materials that are essential for high-technology manufacturing led American leader Donald Trump to propose an additional 100% tariff on imports from the Asian country, raising the possibility of an full-scale commercial conflict between the two economic giants.

The US Treasury Secretary labeled the Chinese action "commercial pressure" and "a international production control attempt."

Questioned on accepting the American proposal to join its dispute with the Asian nation, Reeves said she was "very concerned" by Chinese actions and urged the Chinese government "to avoid restrictions and restrict access."

She said the action was "harmful for the global economy and causes further obstacles."

"I believe there are fields where we should challenge China, but there are also important prospects to sell into China's economy, including financial services and other areas of the economic system. We've got to maintain that equilibrium correct."

The Treasury chief also affirmed she was collaborating with international partners "on our own critical minerals plan, so that we are less reliant."

Health Service Drug Pricing and Investment

Reeves also acknowledged that the cost the NHS pays for drugs could increase as a consequence of current discussions with the Trump administration and its pharmaceutical firms, in return for reduced taxes and investment.

A number of the world's largest pharmaceutical manufacturers have said recently that they are either delaying or abandoning operations in the United Kingdom, with some attributing the insufficient payments they are receiving.

Recently, the government science advisor said the price the NHS spends on drugs would must rise to halt firms and drug research funding leaving the United Kingdom.

Reeves informed the BBC: "We have seen because of the payment system, that drug testing, recent pharmaceuticals have not been offered in the United Kingdom in the way that they are in other European countries."

"Our aim is to make sure that individuals receiving care from the National Health Service are can access the best essential medicines in the world. And so we are looking at these issues, and... seeking to obtain additional capital into the UK."